Label antibodies, small molecules, proteins, or peptides with IVISense NIR fluorescent dyes.
爱游戏平台注册登录 ’s IVISense™ fluorescent dyes (VivoTag®) for labeling antibodies, small molecules, proteins, or peptides are designed specifically to enable customized development of novel superbright fluorescent imaging agents. Dye properties, such as excellent brightness, hydrolytic stability, and photostability, as well as selection for minimal interaction with biological tissue for no potential loss of specificity, have been optimized and validated for use in in vivo or in vitro imaging.
Available as NHS esters or maleimide reactive dyes for conjugation to either free amine (-NH3) or free thiol (-SH) containing molecules. Conjugate an optimal 1-3 dyes onto your protein or choose self-quenching dyes to make your own custom fluorogenic probes.
For research use only. Not for use in diagnostic procedures.
true falsePlease enter valid quantity
Please log in to add favorites.
NULL OR EMPTY CART
IVISense™ 680 NHS fluorescent self-quenching dye. IVISense™ 680 NHS is an amine-reactive NIR fluorochrome for coupling via an NHS ester linkage to peptides, small molecules, proteins, antibodies or macromolecules. Unit size 1 mg.
| Product | Abs/Em (nm) | |
| IVISense NHS FLUORESCENT DYES | ||
| IVISense 645 NHS | 643/660 | Suitable for labeling free amines (typically lysine residues) |
| IVISense 680 NHS | 665/688 | |
| IVISense 800 NHS | 785/810 | |
| IVISense MAL FLUORESCENT DYES | ||
| IVISense 645 MAL | 643/660 | Suitable for labeling free thiols (typically cysteine residues) |
| IVISense 680 MAL | 665/688 | |
| IVISense SELF-QUENCHING DYES | ||
| IVISense 680 NHS | 673/691 | When a protein is labeled with multiple IVISense Self-Quenching Dye molecules, there is a shift in the absorbance of the dye, which will reduce the signal. Only choose IVISense Self-Quenching Dyes if your labeling ratio of dye: protein will be 1:1. If multiple dyes are to be conjugated onto your protein, a non-self-quenching IVISense Dye should be used. NHS dyes are suitable for labeling free amines (typically lysine residues), while MAL dyes are suitable for labeling free thiols (typically cysteine residues). |
| IVISense 750 NHS | 750/775 | |
| IVISense 750 MAL | 750/775 | |
| Optical Imaging Classification | Fluorescence Imaging |
|---|---|
| Product Brand Name | IVISense |
| Shipping Condition | Blue Ice |
| Unit Size | 1 mg |
| Wave Length | 680 nm |
N-Hydroxysuccinimide (NHS)-ester labeling reagents, such as VivoTag®-S reagents, are commonly used for labeling proteins. The NHS ester moiety reacts with amino groups at pH 7-9 to form stable amide bonds. Lysines within proteins, including antibodies, are available as targets for this chemical conj ...
Our comprehensive range of bioluminescent and fluorescent imaging reagents provide researchers with the necessary tools to better understand early disease-related biological changes, track disease progression, help guide the drug discovery process, and evaluate efficacy and safety of drug candida ...
Researchers trust our in vivo imaging solutions to give them reliable, calibrated data that reveals pathway characterization and therapeutic efficacies for a broad range of indications. Our reagents, instruments, and applications support have helped hundreds of research projects over the years. And ...
Fluorescence molecular imaging is the visualization of cellular and biological function in vivo to gain deeper insights into disease processes and treatment effects. Designing an effective study from the beginning can help save time and resources.
Learn about several important best p ...
The goal of in vivo fluorescence molecular imaging is to enable non-invasive visualization and quantification of cellular and biological functioning to better understand and characterize disease processes and treatment effects earlier within the context of a biological system.
This s ...
We have developed a novel FAST (“Fluorescent Activatable Sensor Technology”) in vivo imaging agent based on an angiotensinogen substrate sequences that is selectively cleaved and activated by rodent renin. ReninSense680 FAST, a PKM-modified agent suitable for invivo administration, distributes to th ...
The primary goal of preclinical imaging is to improve the odds of clinical success and reduce drug discovery and development time and costs. Advances in non-invasive in vivo imaging techniques have raised the use of animal models in drug discovery and development to a new level by enabling quick ...
